Progress of Nimotuzumab Application in Nasopharyngeal Carcinoma

Compared with the global average, the incidence rate of nasopharyngeal carcinoma (NPC) in China is higher, particularly in the southern regions where the mortality rate has remained persistently high. Nimotuzumab, a targeted therapy that acts on the epidermal growth factor receptor, has prompted con...

全面介紹

書目詳細資料

Principais autores:	Tianci LIANG, Yue ZHAO, Chenchen SONG, Chaoyi ZHANG, Chen CHEN, Qiaoran LI, Biaoxue RONG
格式:	Artigo
語言:	Chinês
出版:	Magazine House of Cancer Research on Prevention and Treatment 2024-11-01
叢編:	Zhongliu Fangzhi Yanjiu
主題:	nasopharyngeal carcinoma nimotuzumab epidermal growth factor receptor targeted therapy antitumor treatment
在線閱讀:	http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2024.24.0362
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!